T
ARKG icon

Tidemark’s ARK Genomic Revolution ETF ARKG Stock Holding History

Tidemark’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Hold
277
– – ﹤0.01% 488
2026
Q1 		$7.33K Hold
277
– – ﹤0.01% 502
2025
Q4 		$8.03K Hold
277
– – ﹤0.01% 452
2025
Q3 		$7.7K Hold
277
– – ﹤0.01% 485
2025
Q2 		$6.75K Hold
277
– – ﹤0.01% 489
2025
Q1 		$5.76K Hold
277
– – ﹤0.01% 501
2024
Q4 		$6.53K Sell
277
-139
-33% -$3.42K ﹤0.01% 484
2024
Q3 		$10.7K Sell
416
-27
-6% -$688 ﹤0.01% 424
2024
Q2 		$10.4K Sell
443
-987
-69% -$24.9K ﹤0.01% 410
2024
Q1 		$41.1K Sell
1,430
-43
-3% -$1.29K 0.02% 258
2023
Q4 		$48.3K Buy
+1,473
New +$40.1K 0.03% 230

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Tidemark's ARKG Position: Q2 2026 in Review

Tidemark held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 277 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

Tidemark first reported a position in ARKG in Q4 2023 and has held it in 11 quarters since. The position peaked at $48.3K in Q4 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Tidemark held 277 shares of ARK Genomic Revolution ETF worth $11.7K as of Q2 2026.
  • Tidemark left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #488 holding.
  • Tidemark first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's ARK Genomic Revolution ETF position peaked at $48.3K in Q4 2023.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.